<--- Back to Details
First PageDocument Content
Immunosuppressants / Cell signaling / Amgen / Etanercept / Drug design / Drug action / Rheumatoid arthritis / Receptor / Tumor necrosis factor receptor / Biology / Pharmacology / Cell biology
Date: 2012-04-30 03:35:32
Immunosuppressants
Cell signaling
Amgen
Etanercept
Drug design
Drug action
Rheumatoid arthritis
Receptor
Tumor necrosis factor receptor
Biology
Pharmacology
Cell biology

CALIFORNIA STATE SCIENCE FAIR 2012 PROJECT SUMMARY Name(s) Project Number

Add to Reading List

Source URL: www.usc.edu

Download Document from Source Website

File Size: 14,09 KB

Share Document on Facebook

Similar Documents

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

DocID: 1rrNB - View Document

Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2

DocID: 1rmwo - View Document

EAP Reimbursement Criteria for Frequently Requested Drugs

EAP Reimbursement Criteria for Frequently Requested Drugs

DocID: 1rhhE - View Document

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

DocID: 1rakB - View Document

TABLE OF CONTENTS  INTRODUCTION 2

TABLE OF CONTENTS INTRODUCTION 2

DocID: 1qY7G - View Document